A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan
Clinical trial NCT02620306 · COMPLETED
Trial details
- NCT number
- NCT02620306
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-11
- Primary completion
- 2019-12-23
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.